NFKB1 and mantle cell lymphoma: In MCL cells, mutations affecting NF-κB transcription factors or upstream components such as CARD11, TRAF3, and NIK, as well as mutations in the NFKBIE negative regulator of the pathway, are associated with disturbed NF-κB activity [19,23].